Lantern Pharma Inc.
LTRN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001763950
No open-market purchases or sales by Lantern Pharma Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $12.0M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Lantern Pharma Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 21 | 25 | +4 |
| Shares | 1.08M | 1.15M | +68.4K (+6.3%) |
| Value | $5.23M | $6.50M | +$1.26M (+24.1%) |
New holders (5)
Institutions that held Lantern Pharma Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pathway Financial Advisors LLC | 14,001 | $79.0K | 0.03% |
| Susquehanna International Group, LLP | 10,581 | $59.7K | 0.00% |
| Rhumbline Advisers | 228 | $1.28K | 0.00% |
| Advisor Group Holdings, Inc. | 200 | $1.13K | 0.00% |
| Royal Bank of Canada | 206 | $1.00K | 0.00% |
Sold out (1)
Institutions that held Lantern Pharma Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Cranbrook Wealth Management, LLC | 717 | $3.46K |